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Thyroid hormones act as pleiotropic factors in many tissues during development, by regulating genes involved
in differentiation. The adipose tissue, a target of thyroid hormones, is the main place for energy storage and acts as
a regulator of energy balance, sending signals to keep metabolic control. Adipogenesis is a complex process that
involves proliferation of preadipocytes and its differentiation into mature adipocytes. This process is regulated
by several transcription factors (CCAAT=enhancer-binding proteins [C=EBPs], peroxisome proliferator-activated
receptors [PPARs]) that act coordinately, activating adipocyte-specific genes that will provide the adipocytic
phenotype. Thyroid hormones regulate many of those genes, markers of differentiation of adipocytes, those
involved in lipogenesis, lipolysis, and thermogenesis in the brown adipose tissue (BAT). Triiodothyronine (T3)
actions are achieved either directly through specific thyroid response elements (TREs), by regulating other key
genes as PPARs, or through specific isoforms of the nuclear T3 receptors. The availability of T3 is regulated through
the deiodinases D3, D2, and D1. D3 is activated by serum and mitogens during proliferation of preadipocytes,
while D2 is linked to the differentiation program of adipocytes, through the C=EBPs that govern its functionality,
providing the T3 required for thermogenesis and lipogenesis. The relationship between white adipose tissue
(WAT) and BAT and the possible reactivation of WAT by activation of uncoupling protein-1 (UCP1) is discussed.
Introduction
Thyroid hormone actions are pleiotropic, involvingthe regulation of many physiological systems. Their ac-
tions are especially important during development. One of
the best-studied actions of thyroid hormones is the regula-
tion of the metamorphosis of amphibians (1–4). Thyroid hor-
mones regulate the growth and maturation of many organs
and tissues during the fetal and neonatal life (5,6) as well as
other specific organs like the cochlea or specific regions of
the retina (7,8). Many tissues are regulated by thyroid hor-
mones up to their complete development, including actions
on groups of genes involved in the differentiation program.
The supply of thyroid hormones is also regulated in a time-
specific way and in precise areas of the brain, through the
deiodinases D2 and D3, as demonstrated in the human fetal
brain (9) or in the cochlea (10). During the adult life, thyroid
hormones regulate the metabolism and function of many
tissues, such as liver, heart, skin, muscle, or adipose tissue.
The adipose tissue is one of the targets of thyroid hormones.
The adipose tissue is specialized in the transport, synthesis,
storage, and mobilization of lipids. Its main function is the
storage of energy in the formof triglycerides, and it constitutes
a reservoir of energy to be used in times of caloric deprivation.
There are two types of adipose tissue: white adipose tissue
(WAT) and brown adipose tissue (BAT), which have distinct
features. The WAT is considered as a reservoir of lipids and
energy and morphologically is characterized by a large lipid
droplet that fills the cellular space. WAT is distributed in
many different anatomical locations: subcutaneous and vis-
ceral (omental) fat, which have different lipolytic sensitivity
and response to drugs and hormones and represent a differ-
ent health risk (insulin resistance and metabolic syndrome)
(11). But we can find also fat deposits covering other organs
such as the heart, kidney, or the sexual organs (perirenal and
perigonadal depots). To which extent this adipose tissue is
pure WAT is under discussion because some of these loca-
tions are reminiscent of the primitive BAT locations. WAT in
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humans is a large and disperse tissue along the body account-
ing for about 15% of total body weight in control subjects, a
percentage that can increase up to 40% in obese patients.
The BAT is a tissue specialized in the adaptation to cold by
adaptive or facultative thermogenesis or to rich diets (pro-
tection against obesity). BAT is found predominantly in hi-
bernating animals, small rodents, and newborns (12). The
main function of BAT is to dissipate energy instead of storing
it. The dissipation of energy is accomplished by the BAT-
specific protein, uncoupling protein-1 (UCP1), which gener-
ates heat by uncoupling the respiratory chain. BAT is found
in small, disperse locations in the body, protecting heart,
kidneys, aorta, and other organs. It is highly innervated and
irrigated. Morphologically BAT is characterized by multilo-
cular lipid droplets and abundant mitochondria, which in-
crease under cold exposure. The capacity of BAT to dissipate
energy is considered as a possible tool against obesity in case
it could be reactivated.
Proliferation and Differentiation of Adipocytes
The adipose tissue was considered for many years only as
a reservoir of lipids, a place for lipid storage and mobiliza-
tion, but during the last 15 years there has been a burst of
information related to adipose tissue, its regulation, its se-
cretory function, the adipocyte-specific genes, and the sig-
naling pathways altered in pathological situations, leading to
a better knowledge of this tissue and the main features of its
functional unit, the adipocyte.
The research on adipose tissue was hampered for years due
to the difficulties inherent to its high lipid content and the lack
of suitable cell culture models for its molecular study. The
establishment of preadipose cell lines, derived from NIH 3T3
fibroblasts (3T3-L1 and 3T3-F442 cell lines), allowed the study
of the differentiation of the adipocyte. The pioneering studies
from the groups of Spiegelman and Lane have thrown light
on the molecular biology of the adipocyte (13,14). They ini-
tially identified a series of lipogenic and glycolytic enzymes
that increased several fold during the process of the adipocyte
differentiation, by measuring its activity, protein levels, and
mRNAs. Among these markers were the fatty-acid-binding
protein aP2 (15), glycerophosphate dehydrogenase (GPD)
(13), acetyl-CoA carboxylase (ACC) (16), the stearoyl-CoA
desaturase (SCD) (17), the fatty acid synthetase (FAS) (16),
the lactic dehydrogenase (LDH), lipoprotein lipase (LPL),
malic enzyme (ME), phosphoenolpyruvate carboxykinase
(PEPCK), and some new genes as adipsin (18,19) and adipoQ
(20), now called adiponectin. Among those proteins some are
early markers of adipocyte differentiation and others appear
later on, as seen in Figure 1, and as reviewed by Ailhaud et al.
(21). The C=EBPs transcription factors were early identified
by Lane and coworkers as the ones governing the process of
adipocyte differentiation (22,23).
The adipocyte is the functional unit of the adipose tissue.
This cell, specialized in the storage of lipids, acquires its full
capacity after a complex process called adipogenesis, which
involves proliferation from preadipocytes or mesenchymal-
type cells and a coordinated process of differentiation that
confers the adipocyte the full capacity to accomplish its spe-
cialized functions.
Proliferation of preadipocytes
The preadipocyte is a mesenchymal-type cell that derives
from pluripotential stem cells, which become predetermined
to be preadipocyte. The factors that trigger these first steps
from pluripotential stem cells into preadipocytes have not
been elucidated. Osteoblasts, myoblasts, and adipocytes
derive from a common mesenchymal precursor cell (24,25).
Mesenchymal stem cells seem to differentiate into adipocytes
under PPARg2 activation (26), but the intermediate steps
that trigger the activation are far from being identified. Leu-
kemia inhibitory factor (LIF) has been proposed as one of the
markers of these initial steps, inducing the adipocytic phe-
notype together with PPARg2. The preadipocyte factor 1
(Pref-1, also called Dlk1) is an imprinted gene found only in
preadipocytes and is a potent inhibitor of adipogenesis (27).
Pref-1 activates MEK-extracellular signal-regulated kinase
(ERK) phosphorylation (28–30) and is amarker of preadipocyte
stage (Fig. 1). Certain HOX genes display a specific expression
in WAT, and the expression of four HOX genes appears to
discriminate betweenWAT and BAT (31). A recent study using
microarrays has identified Pref-1 as one of the markers of
the proliferative stage in brown preadipocytes, while C=EBPd
and Necdin are markers of proliferating brown and white
preadipocytes (32). Necdin is a transcriptional regulator that
would inhibit the activation of the PPARg1 promoter (33).
The preadipocytes, also called ‘‘precursor’’ cells or
mesenchymal-type cells, present in the stroma-vascular frac-
tion of the adipose tissue, even in adult animals, though they
are present in smaller number. The identification of these
precursor cells has been very important for the research in
adipose tissue because it has allowed to establish primary
cultures of preadipocytes, which proliferate and differenti-
ate in culture (34). The proliferation of preadipocytes occurs
under the stimulation of several growth factors present in
serum, mainly those from the family of the fibroblast growth
factors (FGFs). The proliferation of brown preadipocytes is
highly stimulated under cold exposure and was first studied
in vivo using tritiated thymidine, establishing the b-adrenergic
nature of the process of proliferation (35–37), while insulin
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FIG. 1. Different stages of white adipocyte differentiation
are shown, from precursor cells to mature adipocytes. The en-
zymes and proteins expressed at the different stages of dif-
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was proposed as a mitotic factor for white adipocytes (38).
Studies in primary cultures of brown preadipocytes demon-
strated that the b1 adrenergic stimulation increases DNA
synthesis (39). Our studies showed that norepinephrine (NE),
a poor mitogen itself, increases the mitogenic action of serum,
growth factors, and the neuropeptide vasopressin (40) (Fig.
2A). Therefore, NE has an important role in brown adipocyte
proliferation, besides its role in increasing thermogenesis,
specifically UCP1 mRNA expression.
The role of thyroid hormones during the proliferative
stage of adipocytes seems to be antimitogenic, as the addi-
tion of triiodothyronine (T3) inhibits the mitogenic activity of
bFGF and aFGF in brown preadipocytes (41) (Fig. 2B). In fact,
D3 activity and mRNA are highly induced by growth factors
in primary cultures of brown adipocytes (42,43), suggesting
that a reduction of T3 levels is physiologically important
under mitogenic stimulation. Large D3 increases (activity and
mRNA) are also observed when serum is added to primary
cultures of brown adipocytes (44) (Fig. 3). This led us to
propose that D3 acts as a marker of proliferation in brown
preadipocytes. As opposite, little D2 activity is observed
during the proliferative stages, pointing to a differential role
of both deiodinases, D3 being present during proliferation
and D2 having a role during the differentiation stages.
Proliferation studies using white preadipocytes are scarce,
although serum clearly stimulates DNA synthesis and pro-
liferation in white preadipocytes in primary cultures (un-
published results). The identification of the specific growth
factors responsible for the proliferation of white preadipo-
cytes requires further investigation. It has been postulated
that the proliferation of white preadipocytes requires only
T3, insulin, and transferrin in serum-free medium (45,46).
However, evidence indicates that the preadipocytes of obese
people secrete mitogenic factors that induce a higher prolif-
eration rate than the conditioned media derived from pre-
adipocytes from control subjects (47). Macrophage-secreted
factors have also been proposed as mitogens in human pre-
adipocytes (48), but the specific growth factors or adipokines
involved have not been identified. FGF10 has been proposed
as one of the mitogens for WAT, because the development of
WAT in FGF10= mouse embryos is greatly impaired due
to a decreased proliferative activity of WAT, indicating that
FGF10, not C=EBPa, is required for the proliferation of white
preadipocytes (49). Adipose tissue is a source of growth
factors that could stimulate proliferation, such as insulin
growth factor I (IGF-I), IGF-binding proteins, tumor necrosis
factor a (TNF-a), angiotensin II, and macrophage colony-
stimulating factor (MCSF) (50).
Differentiation of the adipocytes:
the role of transcription factors
The process of adipocyte differentiation was first stud-
ied as a unique process in preadipose cells lines (3T3-L1 and
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FIG. 2. Proliferation of brown preadipocytes. (A) We show the increases in DNA synthesis in brown preadipocytes using
different growth factors (EGF, PDGF, aFGF, and bFGF), alone or combined with Vasopresin (V) and=or norepinephrine (NE).
(B) Antimitotic effect of triiodothyronine (T3) on DNA synthesis induced by growth factors, measured as thymidine in-
corporation (40).
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FIG. 3. Time-course induction of D3 activity (left) and D3 mRNA (right) using 10% newborn calf serum (NCS) in brown
adipocytes (44).
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3T3-F442). Differentiation was usually induced by adding
dexamethasone and agents that increase cAMP (IBMX). T3
was often included in the ‘‘differentiation cocktail.’’ In this
way it is difficult to predict if the effects observed are due to
the process of differentiation itself or to the action of the
hormones added. During the adipose differentiation of 3T3-
F442A or 3T3-L1 cells, there is a large increase in the tran-
scription of specific genes and increases in the synthesis of
numerous proteins, including the lipogenic enzymes GPD,
FAS and ME, and many others as described above (13,16).
There is a sequential activation of a whole set of proteins
and enzymes that act as differentiation markers, with dif-
ferent timings for their transcriptional increases (Fig. 1).
Early markers are LPL or IGF-1, preceded by the families of
transcription factors C=EBPs and PPARg. They are followed
by many lipogenic enzymes and other proteins: GPD, ME,
FAS, aP2, Glut4, ACC, and the b- adrenergic receptors, among
many others. Later markers of differentiation are leptin,
adipsin, PEPCK, the a-2 adrenergic receptors, and others (21).
Recently, studies using genomic techniques (microarrays)
(51) have shown that the cellular programs associated with
adipocyte differentiation are more complex than previously
thought as derived from the changes observed in vitro in the
mentioned cell lines and the changes in gene expression as-
sociated with adipocyte development, revealing that adipo-
cyte differentiation in vivo and in vitro are quite different.
Those studies confirmed many genes that had been previ-
ously reported to increase during differentiation of cell lines,
for example, C=EBPd, C=EBPb, C=EBPa, aP2, adipsin, adi-
ponectin, LPL, HSL, SCD1, GPD, and so on. Other genes were
induced later on, as PEPCK, b3-AR, PFKI, IGF-II, and so on.
But several genes were expressed only in cell lines in vitro or
only cells derived from tissues in vivo. These data suggest that
one or more transcriptional programs are activated exclu-
sively in vivo to generate the adipocyte phenotype.
Therefore, the differentiation of preadipocytes into adipo-
cytes is achieved by the coordinate activation of transcrip-
tion of several adipose-specific genes (52). The adipocyte
differentiation follows a common adipogenic transcriptio-
nal pathway, regulated by the transcription factor families
of C=EBPs and PPARs. All the adipogenesis is regulated by
the sequential activation of these transcription factors and the
nuclear proteins (coactivators or inhibitors) that regulate
them.
The C=EBPs are transcription factors of the basic leucine
zipper family. Several members of the C=EBP family
(C=EBPa, C=EBPb, and C=EBPd) have tissue-specific expres-
sion patterns and recognize a common DNA-binding ele-
ment. C=EBPa is expressed in brown and white adipose
tissues, placenta, and liver. C=EBPa is a master regulator
of adipose tissue development. C=EBPa is required for the
differentiation of 3T3-L1 preadipocytes, and when over-
expressed, is able to trigger the differentiation of 3T3-L1
preadipocytes. It also works as an antimitotic signal inducing
proteins associated with growth arrest (GADD45 and p21)
(53). The induction of C=EBPa in preadipocytes increases the
expression of several adipocyte-specific genes (aP2, Glut4)
and the accumulation of triglycerides (53,54).
The C=EBPb and possibly C=EBPd transcription factors are
expressed earlier than C=EBPa in the differentiation program
and activate transcriptionally C=EBPa, triggering the process
of differentiation, while PPARg and C=EBPa induce the dif-
ferentiation from preadipocytes into adipocytes, followed by
the adipo-specific gene expression. Most of those genes
(SCD1, aP2, S14, PEPCK, and Glut4) have C=EBP-binding
domains in their promoters and are activated in a coordinated
program during adipogenesis (22), and we cannot forget to
include two important ones for the differentiation of brown
adipocytes, UCP1 and D2, which we will comment later on.
C=EBPb and C=EBPd increases precede those of C=EBPa.
During the development of BAT during fetal life, C=EBPb and
C=EBPd increases also precede C=EBPa expression (55).
The study of the mice with a deletion in the C=EBPa gene
(C=EBPa knockout mice) throws some light on the function
of this transcription factor. The knockout mice die shortly
after birth due to severe hypoglycemia and defective hepatic
glycogen storage and gluconeogenesis (56). C=EBPa knock-
out mice do not have WAT and showed a great reduction in
BAT depots and a very low UCP1 mRNA expression. This
shows that C=EBPa is essential for the survival of the mice
and for the developmental program of liver and adipose
tissue. The status of BAT was examined in the C=EBPa
knockout mice (57). UCP1 expression was very low; adipo-
genesis was impaired; the size, number, and function of the
mitochondria were reduced. The expression of thyroid hor-
mone receptors (THRs) and PGC1 (the coactivator of PPARg)
was delayed (57). We found that BAT D2 activity was very
low (Fig. 4), together with low T3 levels in BAT; this indi-
cates that C=EBPa is critical to maintain thyroidal status in
BAT. Indeed, D2 has C=EBP elements in its proximal pro-
moter. This suggests that D2 plays a crucial role in the dif-
ferentiation program of fetal BAT and in some way is linked
to it for its full functionality, possibly because T3 is abso-
lutely necessary for its function.
Neonatal hypothyroidism decreases C=EBPa and C=EBPb
expression in liver, but not in BAT (58), and several TREs
have been identified in the C=EBPa promoter (59). In the
PEPCK gene, a relationship between C=EBPs and TREs has
been described, as in this gene the activation of C=EBPs is
required for a functional TRE (60).
Besides the participation of the C=EBPs, adipocyte differ-
entiation is a process regulated also by the PPAR family,
specifically by PPARg. PPARs belong to the family of nuclear
FIG. 4. D2 activity in fetal (d17 and d18) and neonatal (NB)
BAT of CCAAT=enhancer-binding protein (C=EBP) knockout
mice andwild-typemice (57). *** refers to p<0.05 vswild type.
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receptors that act as transcription factors regulating changes
in gene expression in response to nutritional stimuli and con-
trolling lipid metabolism. PPARs family controls the metab-
olism of fatty acids, which are natural ligands that activate
PPARs, especially arachidonic acid and its metabolites. PPAR
family has several members: PPARa (activated by fibrate and
regulates b-oxidation, lipid catabolism, and inflammation),
PPARd, and PPARg, which is quite specific of adipose tissue.
PPARs form heterodimers with the X receptor of retinoic
acid (RXR), activating the PPAR response elements (PPREs)
(DR-1, 6-base pair direct repeats of the sequence RGGTCA
spaced by one base) present in the promoter of specific target
genes. Most of the genes mentioned above have PPREs in their
promoters: aP2, FAS, PEPCK, LPL, SCD, and so on. Those
PPRE-binding sites can bind different isoforms in different
tissues, for example, for the LPLgene, the PPARa isoform in the
liver and the PPARg isoform in the adipose tissue. There is
abundant information that indicates that PPARs play impor-
tant roles not only in adipogenesis but also in inflammation,
atherogenesis, glucose homeostasis, and cancer.
All the adipogenesis is regulated by the activation of the
PPARg (61), which in turn is regulated by C=EBPa and pos-
sibly by C=EBPb (Fig. 5). The ectopical expression of PPARg is
able to induce fibroblastic cell lines to differentiate into adi-
pocytes under the appropriate stimuli of agonists of PPARg
(thiazolidinediones) (61).
As the mice with targeted deletion of PPARg were lethal,
several strategies have been used; the main one was to use
the adipose-specific PPARg knockout mice. PPARg knockout
mice presented several alterations with contrasting results.
Some studies have showed a reduced fat formation, and
protection against obesity and insulin resistance with lipo-
dystrophy (62). The mice with targeted deletion of PPARg2
have insulin resistance, indicating that PPARg2 is necessary
for the maintenance of insulin sensitivity (63).
The specific coactivator of PPARg, PGC1, was identified in
1998 (64). PGC1 greatly increased under cold exposure in
BAT. PGC1 increased the transcriptional activity of PPARg
and THR on the UCP1 promoter. As the ectopic expression of
PGC1 in white adipocytes activated the expression of UCP1
and mitochondrial enzymes of the respiratory chain, PGC1
was considered as the true transcriptional activator of BAT
and adaptative thermogenesis, as well as a marker of brown
adipocytes (64). Later on, it has been identified as funda-
mental for several processes like hepatic gluconeogenesis,
heart function in which mitochondriogenesis is very impor-
tant, and inflammation (65–67).
The mice with targeted deletion of PGC1a present several
abnormalities in muscle, hepatic steatosis, increase in body
fat, diminished mitochondrial number and respiratory ca-
pacity, and abnormal cardiac function (68). The importance
of the coactivator of PPARg, PGC1, is explained in one of the
previous chapters (Chapter 8).
Regulation of gene expression in adipocytes
by T3 and its nuclear receptors
T3 regulates adipogenesis and processes related to them as
lipogenesis and lipolysis both in vivo and in cultured adipo-
cytes (21,69). Indeed, all the isoforms of THRs, TRa1, TRa2,
and TRb1, are expressed in white and brown adipocytes and
in WAT and BAT, TRa1 being the predominant TR isoform
(70–73). T3 and other hormones regulate the different TR
isoforms. Two main approaches have been used to discrimi-
nate between the effects of both TR isoforms: a pharmaco-
logical approach, using ligands specific of the TRb isoform,
and a genetic approach, using knockout and knockin mice.
Selective agonists of the TRb isoform have been used to
increase metabolic rate and lower cholesterol, triglycerides,
lipoproteinA, and body weight without affecting heart rate
(74). The TRb1 agonist GC-1 was used to stimulate UCP1,
with no effect in regulating body temperature, therefore
discriminating two isoform-specific actions of T3 in BAT (75).
To identify the specific actions of the a- and b-TR isoforms,
several TR knockout and knockin mice were generated (76).
Although the first knockout mice studied did not show
phenotypic abnormalities concerning adipose tissue metab-
olism or alterations in energy balance, recent work has
identified several phenotypes related to adipose tissue and
energy balance, due to point mutations or negative dominant
mutations in the TRs. TRa seems to be required for proper
thermogenesis (77), while TRb regulates cholesterol metabo-
lism (78). Mice devoid of all TRs have decreased body tem-
perature and basal metabolic rate and are cold intolerant due
to insufficient heat production (79). These null TR mice show
growth retardation and delayed skeletal maturation together
with an increased amount of fat and increases in several
adipocyte-specific genes (80). Moreover, certain mutations in
the THRs, specifically the P398H mutation in the TRa gene,
induce visceral adiposity, hyperleptinemia, a fourfold in-
crease in body fat, increased basal glucose and insulin, and
impaired lipolysis in male mice (81). Many genes of the li-
pogenic and lipolytic pathways were decreased. Adaptative
thermogenesis was also reduced. This mutation reduces the
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FIG. 5. Transcription factors that regulate the differentia-
tion of adipocytes. The role of the coactivator of PPARg,
PGC1, is also depicted. Modified from Puigserver and Spie-
gelman (65).
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PPARa binding to PPREs, interfering with PPARa signal-
ing (82). Recently, the role of unliganded TRs, acting as
aporeceptors and exerting opposite transcriptional effects,
has been investigated using a dominant negative mutation
(R384C) in the TRa1 gene that causes a 10-fold reduction in
the affinity to T3 (83). These mice were hypermetabolic and
had reduced fat depots, hyperphagia, and resistance to diet-
induced obesity, together with an induction of the genes
involved in glucose handling and lipid mobilization and
b-oxidation. The alterations are reversed by increases in T3
levels. Thus, TRa1 aporeceptor is involved in metabolic ho-
meostasis. Similar results are found in other heterozygous
mice with a dominant negative mutation of the TRa1 (PV=þ),
in which WAT is reduced, as well as the expression of PPARg
signaling, affecting adipogenesis (84).
Many of the genes involved in the differentiation program
of adipocytes are regulated by T3. The list of genes includes
GPD, ME, PEPCK, S14 (85), FAS (86), GLUT4, and LPL,
among many others (87–89). Many of those genes are directly
regulated by T3 through the TREs present in their promoters
(90–92). Some enzymes such as a-glycerophosphate dehy-
drogenase (a-GPDH) and ME have been used extensively to
check the thyroidal status in experimental animals (usually
in liver). Many groups accomplished the study of the T3 ac-
tions at the promoter level, identifying the functional TREs
and its interactions with other members of the family of
nuclear receptors, such as PPARs, retinoic acid, or with in-
sulin response element (IRE) and cAMP response elements
(CREs). Usually there is a strong interaction among all these
elements and the coactivators that regulate them, as have
been described in several genes as UCP1, ME, ACC, and
others. We studied the regulation of ME and S14 by T3 in
brown preadipocytes in culture (93–95). ME is a lipogenic
enzyme that plays a key role in differentiation, and S14, a T3-
responding gene and abundant in lipogenic tissues, is now
considered a possible transcription factor in lipogenesis.
These two genes increase during differentiation of preadipo-
cytes, and its natural progression increases in the presence of
by T3. The action of T3 is both transcriptional and stabilizing
the mRNA, and it is synergic with the action of insulin. The
effect of NE and retinoic acid was also examined (94). A detail
study of the effect of T3 on lipid synthesis is presented in the
next chapter.
T3 actions on UCP1 and thermogenesis: role of D2
When working with 3T3-L1 preadipocytes (white), the
differentiation of adipocytes is measured by its lipogenic
capacity and the capacity for lipid accumulation, measuring
the increase in lipid droplets and increased gene expression
in lipogenic enzymes. But in BAT, the differentiation process
involves in addition the acquisition of the full thermogenic
capacity, as measured by the full expression of UCP1 and the
activation of the process of mitochondriogenesis.
As described above, the function of BAT is to generate heat
when the demands increase under cold exposure. The gen-
eration of extra heat is accomplished by the mitochondrial
UCP1 that uncouples the oxidative phosphorylation. BAT is
activated by the sympathetic nervous system (SNS), via the
NE released from the nerve endings (96). The binding of NE
to the adrenergic receptors and the activation of adenylate
cyclase increases cAMP, that activate lipolysis, increasing free
fatty acids (FFA) which activates UCP1 (12). The thermogenic
capacity of BAT is determined by the amount of UCP1. UCP1
is transcriptionally activated shortly after NE or cold expo-
sure (97,98). It has been demonstrated that T3 amplifies the
adrenergic stimulation of UCP1 (98,99). Moreover, in ther-
moneutral conditions, like during the intrauterine life, T3 is
required for the expression of UCP1 mRNA, and euthyroid-
ism is required during the first postnatal days for the in-
creases in UCP1 mRNA (Fig. 6) (100,101). In cultures of rat
brown adipocytes, it is clear that T3 is an absolute require-
ment for UCP1 adrenergic increases, participating in the
stabilization of mRNA transcripts (102). T3 itself is also able
to induce the transcription of UCP1 in fetal rat brown adi-
pocyte in primary culture (103).
The study of the UCP1 promoter provided evidence for the
presence of CREs (104–106) in the proximal promoter, and
an enhancer element was identified that contained several
TREs (92,107), some retinoic acid response elements (RAREs)
(108,109), and a PPRE (110). There is clear cross-talk among
these nuclear receptors and its coactivators for its binding to
the UCP1 promoter. In addition, there are negative regulators
of the expression of UCP1: serum, mitotic signals involving
the activation of c-jun (106), and insulin. Other hormonal
treatments (glucocorticoids or sexual hormones) can also
modulate UCP1 expression.
Recently, we have examined the role of Triac in cultured
brown adipocytes (111). Triac, which binds better than T3 to
the TRb isoform, is 10–50-fold more potent than T3 in in-
creasing the adrenergic induction of UCP1 and D2, as well as
LPL mRNA. The role of Triac was studied in rats (112). Triac
was again more potent than T3 (in terms of doses and con-
centrations) in the stimulation of UCP1, LPL, and leptin, and
at low doses, induced ectopic UCP1 expression in WAT (112).
The adrenergic input also increases D2 deiodinase in BAT
(113), causing amarked increase in T3 in BAT, suggesting that
T3 plays an important role in this process. It was also dem-
onstrated that the intracellular conversion of thyroxine to T3
was required for the full thermogenic function of BAT (114).
This is also true for the adrenergic stimulation of D2 (115,116),
which does not take place unless T3 is present. It is evident
that D2 participates in the formation of BAT, as evidenced in
the experiments described above in C=EBPa knockout mice
FIG. 6. Expression of uncoupling protein (UCP1) in fetal
and neonatal BAT obtained from control and hypothyroid
fetus and litters. Hypothyroidism was induced using methyl-
mercapto-imidazol (MMI) in the drinking water (100).
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(57), where UCP1 expression and D2 activity are blunted, as
well as other markers of mitochondriogenesis. D2 has also
been implicated in the process of lipogenesis under adrenergic
stimuli (89). The analysis of the D2 knockout mice reveals that
there is a hyperadrenergic stimulation, which compensates
for the lack of T3 production in BAT. Lipogenesis is unable to
provide the high FFA levels required during cold exposure,
resulting in an impaired adaptative thermogenesis (117).
The importance of deiodinases in the differentiation of
white adipocytes is still poorly studied. It is evident that there
is a role in lipogenesis and in the expression of genes involved
in the differentiation program. In addition D1 is found in
WAT (118), but its precise role has not been studied. To what
extent the role of D2 and D1 is different from that studied in
brown adipocytes remains to be seen.
The distinction between white and brown adipocytes:
reinduction of WAT into BAT
There are important questions on the relationships between
white and brown adipocytes. In the early 1980s, comparative
studies using primary cultures of brown and white adipo-
cytes (34) established that precursor cells from epididymal fat
(pure WAT) and from interscapular BAT differentiate into
white and brown adipocytes, respectively, with different
phenotypes, characteristics, and regulation. The work done
for more than 20 years using these primary cultures confirms
the hypothesis that precursor cells are already committed to
become brown or white adipocytes. The question whether
BAT and WAT derive from the same or different preadipo-
cyte precursor cells is still under discussion. It is not known
if the undetermined mesenchymal stem cells retain some
myogenic or chondrogenic potential, as many reports have
proposed. Recently, Timmons et al. have analyzed this prob-
lem using microarrays to study both preadipocytes in culture
(32). They have found a myogenic signature in brown pre-
adipocytes, not found in white adipocytes, in which they
have found a transcription factor, Tcf21, which suppresses
myogenesis. They have found genes only expressed in brown
adipocytes or only in white adipocytes, as well as markers of
differentiation and proliferation for white and brown pre-
adipocytes and genes implicated in human obesity (32).
There is a growing interest in this field as brown adipo-
cytes are associated to increased energy expenditure and the
conversion of white adipocytes into brown adipocytes is
sought as a strategy to fight obesity. Indeed under extreme
cold exposure, a reactivation of BAT adipocytes in inguinal
WAT is observed, and this type of WAT was called convert-
ible adipose tissue due to its capacity to revert to BAT (119).
Many attempts have been made in this sense, and there are
an increased number of experimental models in which a re-
activation ofWAT into BAT is observed. The increase inUCP1
expression is the golden rule to assess such a conversion of
WAT into BAT. This fact has been observed using some drugs
and also in mice with targeted deletion of a certain genes. Beta
3 adrenergic agonists are able to induce UCP1 in muscle, and
ectopic BAT present in muscle provides a mechanism against
weight gain (120). Brown adipocytes are also found in WAT
(121–123). The same effect is observed using models of hyper-
leptinemia that depletes fat stores in rats (124,125). Tungstate
has a similar effect with reactivation of energy metabolism
(126), and we observed that Triac at low doses induce UCP1
expression in inguinal WAT in rats (112). In mice with tar-
geted deletion of the corepressor RIP140 (127), UCP1 ex-
pression is increased and the mice are lean and resistant to
diet-induced obesity.
Conclusion
In summary, adipogenesis is a complex process that in-
volves activation of transcription ofmany genes and enzymes,
in a cascade of events regulated by transcription factors that
rule the process of differentiation (C=EBPs, PPARs, and
PGC1). T3 regulates many of the enzymes involved in this
process, either directly or through the interaction with other
coactivators, such as PPARs. The deiodinases play a role by
providing the T3 necessary for this process or limiting its lev-
els. D3 is stimulated by proliferation, while D2 plays a crucial
role in the development of the tissue, in thermogenesis and
lipogenesis. The reactivation of WAT depots into depots con-
taining BAT adipocytes could be achieved by some drugs and
is observed in some models.
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